It will only happen when $200 million is "nothing" to a company. Pharmaceutical companies have an equivalent of "chief aquisition officer" who deals with finding partners and aquiring companies, but they only do that because the cost of developing a succesful drug is ~ $1 billion (no exageration). Drug companies often partner with someone and will aquire them if the partnership proves fruitful.
It is often much quicker, and ultimately cheaper, to aquire someone than to develop the software themselves. When software development costs reach the dizzy heights of drug development costs, then there will be the necessity for a cheif aquisition/partnership officier.
It is often much quicker, and ultimately cheaper, to aquire someone than to develop the software themselves. When software development costs reach the dizzy heights of drug development costs, then there will be the necessity for a cheif aquisition/partnership officier.